World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
36520
World Ranking
1063
National Ranking
19

Medicine

D-Index
91
Citations
36983
World Ranking
11611
National Ranking
470

John C. Bell publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John C. Bell sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 352 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John C. Bell D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John C. Bell sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John C. Bell is affiliated with the University of Ottawa in Canada. Their research focuses on several fields within biology and medicine, prominently including biochemistry, genetics and molecular biology, and medicine. The scientist's work spans multiple subfields such as genetics, molecular biology, oncology, infectious diseases, and immunology.

Key topics covered in their research include:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 research
  • Cancer research and treatments
  • Animal virus infections studies
  • Immunotherapy and immune responses
  • Viral infectious diseases and gene expression in insects

John C. Bell has contributed to a number of recent scholarly articles. These include:

  • Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy, 2020, Molecular Therapy - Oncolytics
  • Extracellular Vesicles and Viruses: Two Intertwined Entities, 2023, International Journal of Molecular Sciences
  • Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination, 2021, Nature Communications
  • Engineering and combining oncolytic measles virus for cancer therapy, 2020, Cytokine & Growth Factor Reviews
  • Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy, 2022, Nature Communications

The scientist works collaboratively with several frequent co-authors, including Carolina S. Ilkow, Taha Azad, Mathieu J. F. Crupi, Stephen Boulton, and Ragunath Singaravelu.

Their publications appear regularly in several scientific venues. Frequent publication outlets comprise:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Molecular Therapy
  • Nature Communications
  • Cancer Immunology Research

Best Publications

  • An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress

    Heather P. Harding;Yuhong Zhang;Huiquing Zeng;Isabel Novoa

  • Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase

    Gregory E. Hannigan;Chungyee Leung-Hagesteijn;Linda Fitz-Gibbon;Marc G. Coppolino;Marc G. Coppolino

  • Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

    David F. Stojdl;Brian Lichty;Shane Knowles;Ricardo Marius

  • VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

    David F Stojdl;Brian D Lichty;Benjamin R tenOever;Jennifer M Paterson

  • ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth

    Meixia Bi;Christine Naczki;Marianne Koritzinsky;Diane Fels

  • Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

    Jeong Heo;Tony Reid;Leyo Ruo;Caroline J. Breitbach

  • ONCOLYTIC VIROTHERAPY

    Unknown

  • Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

    Joy Hsu;Jonathan J. Hodgins;Malvika Marathe;Chris J. Nicolai

  • The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.

    Karen Colwill;Tony Pawson;Brenda Andrews;Jayendra Prasad

  • Recent progress in the battle between oncolytic viruses and tumours.

    Kelley A. Parato;Donna Senger;Peter A. J. Forsyth;John C. Bell

  • Going viral with cancer immunotherapy

    Brian D. Lichty;Caroline J. Breitbach;David F. Stojdl;John C. Bell

  • Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

    Caroline J. Breitbach;James Burke;Derek Jonker;Derek Jonker;Joe Stephenson

  • Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

    Byeong Ho Park;Taeho Hwang;Taeho Hwang;Ta Chiang Liu;Daniel Y. Sze

  • Activating transcription factor 4 is translationally regulated by hypoxic stress.

    Jaime D. Blais;Vasilisa Filipenko;Meixia Bi;Heather P. Harding

  • Vesicular stomatitis virus: re-inventing the bullet

    Brian D Lichty;Anthony T Power;David F Stojdl;John C Bell

  • Oncolytic viruses as engineering platforms for combination immunotherapy.

    Kwame Twumasi-Boateng;Jessica L Pettigrew;Y Y Eunice Kwok;John C Bell;John C Bell

  • Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

    Caroline J Breitbach;Jennifer M Paterson;Chantal G Lemay;Theresa J Falls

  • Translational control of the innate immune response through IRF-7

    Rodney Colina;Mauro Costa-Mattioli;Ryan J. O. Dowling;Maritza Jaramillo

  • Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress

    Jaime D. Blais;Christina L. Addison;Robert Edge;Theresa Falls

  • Cloning and characterization of a second member of the mouse mdr gene family.

    P Gros;M Raymond;J Bell;D Housman

  • Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR.

    Ninan Abraham;David F. Stojdl;Peter I. Duncan;Nathalie Méthot

Frequent Co-Authors

Brian D. Lichty
Brian D. Lichty McMaster University
David Kirn
David Kirn University of California, Berkeley
John Hiscott
John Hiscott Istituto Pasteur
Nahum Sonenberg
Nahum Sonenberg McGill University
Barbara C. Vanderhyden
Barbara C. Vanderhyden University of Ottawa
Brad H. Nelson
Brad H. Nelson University of British Columbia
Grant McFadden
Grant McFadden Arizona State University
Michael W. McBurney
Michael W. McBurney University of Ottawa
Alan Melcher
Alan Melcher Institute of Cancer Research
Christof von Kalle
Christof von Kalle Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various healthcare and research careers. For those interested in nursing, programs like the easiest absn program to get into offer a fast track to becoming a Bachelor of Science in Nursing graduate. These accelerated paths are perfect for career changers or those seeking a quicker route into the healthcare field.

If you’re aiming for a practical nursing career, finding lpn schools easy to get into can help ease your entry into the profession. Licensed Practical Nurses play a crucial role in patient care, and accessible programs pave the way for steady career growth.

For advanced practice nurses interested in specialization, understanding what is the easiest np program can guide choices toward manageable pathways that balance workload and certification requirements. Additionally, those with a focus on mental health may find the best pmhnp programs invaluable, as they offer strong clinical placements essential for Psychiatric Mental Health Nurse Practitioners.

Overall, these online degrees and career pathways provide flexible, accessible options for students passionate about advancing their knowledge and impact in immunology and healthcare.

Best Scientists Citing John C. Bell

Trending Scientists

Recently Published Articles